Minerva Neurosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease.
NERV Key Statistics
Stock Snapshot
The current Minerva Neurosciences(NERV) stock price is $6.33, with a market capitalization of 277.3M. The stock trades at a price-to-earnings (P/E) ratio of -0.23.
On 2026-05-04, Minerva Neurosciences(NERV) stock traded between a low of $6.08 and a high of $6.39. Shares are currently priced at $6.33, which is +4.0% above the low and -1.0% below the high.
The Minerva Neurosciences(NERV)'s current trading volume is 18.22K, compared to an average daily volume of 152.55K.
In the last year, Minerva Neurosciences(NERV) shares hit a 52-week high of $12.46 and a 52-week low of $1.30.
In the last year, Minerva Neurosciences(NERV) shares hit a 52-week high of $12.46 and a 52-week low of $1.30.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.